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ABSTRACT  Protein 4.1 is a crucial component of the erythrocyte membrane skeleton. Respon- 
sible  for the amplification  of the spectrin-actin  interaction,  its  presence  is  required  for the 
maintenance of erythrocyte integrity. We have demonstrated a 4.1 -like protein in nonerythroid 
cells.  An antibody was raised to erythrocyte protein 4.1  purified  by KCl  extraction (Tyler,  J. 
M., W.  R.  Hargreaves,  and D.  Branton, 1979, Proc. Natl. Acad. Sci. USA, 76:5192-5196), and 
used  to  identify  a  serologically  cross-reactive  protein  in  polymorphonuclear  leukocytes, 
platelets,  and lymphoid  cells.  The cross-reactive  protein(s)  were  localized to various  regions 
of the cells  by  immunofluorescence  microscopy.  Quantitative  adsorption  studies  indicated 
that  at  least  30-60%  of  the  anti-4.1  antibodies  reacted  with  this  protein,  demonstrating 
significant homology between the erythroid and nonerythroid species. A homologous peptide 
doublet was observed  on  immunopeptide  maps, although there was  not complete  identity 
between the two  proteins.  When  compared with  erythrocyte protein 4.1,  the  nonerythroid 
protein(s)  displayed a lower molecular weight--68,000 as compared with 78,000-and did not 
bind  spectrin  or  the  nonerythroid  actin-binding  protein  filamin.  There  was  no  detectable 
cross-reactivity between human acumentin or human tropomyosin-binding protein, which are 
similarly sized actin-associated  proteins, and erythrocyte protein 4.1. The possible  origin and 
significance of 4.1-related protein(s)  in nonerythroid cells are discussed. 
The erythrocyte provides a unique system for the investigation 
of the protein interactions required for the maintenance of a 
membrane skeleton.  It is the  skeleton,  providing a  durable 
yet  flexible  framework,  that  determines  erythrocyte mem- 
brane  shape,  deformability,  and  structural  integrity  (1-5). 
Operationally defined as the network of proteins remaining 
after erythrocytes are solubilized in nonionic detergents, the 
skeleton consists of spectrin; actin; proteins 2.1 (ankyrin), 4.1, 
and  4.9;  and  a  portion  of protein(s)  7  (1,  5,  6).  Spectrin 
heterodimers,  the  major  components  of the  skeleton,  are 
bound  head  to  head  to  form  tetramers  and  higher-order 
oligomers (7).  Heterodimers are also bound to ankyrin, pro- 
tein 4.1, and actin (for a review, see reference 8). Protein 4.1 
is a globular protein with a molecular weight of ~78,000 (9- 
11). It is phosphorylated and carboxymethylated (12,  13), but 
the  function  of these  posttranslational  modifications is  not 
known.  When  electrophoresed on  the  discontinuous  SDS- 
polyacrylamide gel system of Laemmli, it can be resolved into 
two closely spaced bands, 4. la and 4. lb (13,  14). These bands 
are structurally similar and functionally indistinguishable (13) 
and are therefore generally referred to as protein 4.1.  Protein 
4.1  is required for the binding of F-actin to the cytoplasmic 
surface of  membrane vesicles containing spectrin (15). It binds 
to spectrin dimers at the same end to which actin filaments 
bind (16),  and this binding amplifies the interaction of spec- 
trin  and  F-actin  in  vitro (3,  17-19).  Binding  of 125I-4.1 to 
spectrin in vitro is specific and saturable, with a KD of 1-2 × 
10  -7 M  at pH 7.6  (16, 20).  At saturation, two molecules of 
protein 4.1 can be bound to each spectrin dimer. A compar- 
ison of the number of molecules of spectrin dimer and protein 
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the ratio of these proteins is l:l. 
Until recently, some investigators believed the erythrocyte 
membrane skeleton was an anomaly, the structural elements 
of which bore little or no resemblance to those of the other 
cells of the body. It is now clear, however, that several skeletal 
proteins previously thought to be unique to the erythrocyte 
are found in a variety of nonerythroid cells. Polyclonal anti- 
bodies prepared against ankyrin, the high-affinity membrane 
attachment site for spectrin, have been used to document the 
presence of ankyrinlike proteins in neutrophiis, platelets, and 
brain (21), as well as in the microtubule network of cultured 
cells (22).  Spectrinlike proteins have also been identified in 
many mammalian cells (23-26). Fodrin (brain spectrin) was 
first  described  as  a  high-molecular-weight,  axonally trans- 
ported, spectrinlike protein in mammalian brain, and is also 
found beneath the plasma membranes of lymphocytes (27- 
30,  31).  The  terminal  web  protein,  TW  260/240,  another 
spectrin  analogue,  has  been  purified from  intestinal  brush 
borders (32,  33). 
In an attempt to extend the analogy between the cytoskel- 
etons  of erythrocytes and  those  of other cells,  we  raised  a 
polyclonal  antibody  directed  specifically  against  purified 
erythrocyte protein  4. I.  Using  this  antibody,  we  identified 
and characterized a protein 4. l  analogue in polymorphonu- 
clear leukocytes, platelets, and lymphoid cells. 
MATERIALS  AND  METHODS 
Cell and Antigen Preparation:  Erythrocyte ghosts  were prepared 
according to the method of Fairbanks  et al. (11). Spectrin-depleted inside-out 
erythrocyte vesicles were prepared by centrifugation over dextran (34). Spectrin 
dimer was prepared according to Harris and Lux (35). Protein 4.1 was purified 
by salt extraction  (9) or by a  high-yield detergent  extraction  (36). The two 
preparations  were  used  interchangeably,  and  no  differences  were  noted  in 
antigenicity  or binding  activity.  Acumentin  was purified  from  human poly- 
morphonuclear leukocytes by the method of Southwick et al. (37). Filamin was 
the gift of Dr. J. Hartwig (Massachusetts General Hospital, Boston, MA). 
Human 0olymorphonuclear  leukocytes (PMNs) ~  and a lymphocyte-mono- 
cyte fraction  were obtained  from  fresh, anticoagulated  human blood  by the 
method of Boyum (38). To inhibit  proteolysis they were treated  with  1 mM 
diisopropylfluorophosphate  (DFP);  10 mM N-ethylmaleimide; or with a mix- 
ture of 1 mM DFP,  50 uM [L-trans-epoxysuccinylleucylamido(3-methyl)]bu- 
tane  (Ep-475) (39), an inhibitor  of cysteine proteases (the gift of Dr.  Alfred 
Goldberg and Dr. Vickie Baracos, Harvard  Medical School, Boston, MA),  1 
ug/ml each of pepstatin, chymostatin, antipain, and leupeptin (Sigma Chemical 
Co., St.  Louis,  MO), and  1 mM Na tetrathionate.  To isolate platelets, fresh 
human blood was withdrawn  into citrate-phosphate-dextrose  and was centri- 
fuged at 250 g for 10 min. The platelet-rich plasma layer was retained, diluted 
1:1  with  phosphate-buffered  saline  (PBS:  150  mM  NaCI,  7.5  mM  sodium 
phosphate, pH 7.4) made  10 mM in EDTA, and recentrifuged at 250g for 10 
min to pellet contaminating  PMNs and lymphocytes. This step was repeated 
twice more.  The platelet-rich suspension  was then centrifuged at  1,000 g for 
10-20  min and  the  platelet  pellet was washed  in  PBS and  10  mM  EDTA 
containing  either  1 mM DFP;  10 mM N-ethylmaleimide;  or 1 mM DFP,  50 
uM Ep-475,  1 ~g/ml each of pepstatin,  chymostatin,  antipain,  and leupeptin, 
and  1 mM Na tetrathionate.  All steps but the  last were performed  at room 
temperature  to prevent platelet activation  and aggregation. Platelet cytoskele- 
tons were prepared by Triton  X-100 extraction (40). 
To examine  lymphoid  cells, Triton X-100-extracted  membrane cytoskele- 
tons of the  murine tumor cell line  P815 were prepared  by the  method of 
Lemonnier et al. (41) and were the gift of Dr. M. F. Mescher and Dr. J. Apgar 
(Harvard  Medical  School).  Protein  determinations  were  by  the  method  of 
Lowry et al. (42). 
Antibody Preparation:  To prepare anti-4.1 antibodies, rabbits were 
injected subcutaneously with 50 ug of sodium dodecyl sulfate (SDS)-denatured 
~  Abbreviations used in this paper. DFP, diisopropylfluorophosphate; 
DNP, dinitrophenyl; PMN,  polymorphonuclear leukocyte; RIA, ra- 
dioimmunoassay; TMBP, tropomyosin binding protein. 
protein  4. I (prepared  by dissolving the antigen in  1% SDS and boiling for  1 
rain),  emulsified  in an equal  volume  of Freund's complete  adjuvant  (Miles 
Laboratories,  Inc.,  Elkhart,  IN).  A  boosting  dose  of antigen  (50  ug)  was 
administered  in  incomplete  Freund's adjuvant  21 d  after  the  first injection. 
Blood was collected 7, 9, and  I 1 d after the second injection.  Thereafter  the 
animals were maintained  on a bimonthly schedule of boosting with 50 ug of 
the same protein subcutaneously and bleeding 7 d later. The blood was allowed 
to clot  at  37"C for  1 h,  and  then placed  at  4"C overnight  to  facilitate clot 
retraction. After centrifugation at 27,000 g for 20 rain, the serum was collected 
and the clot discarded. IgG was purified from immune serum as described by 
Cebra and Goldstein (43). 
Antibody Characterization:  Immune sera were characterized by a 
solid-phase radioimmunoassay  (RIA) (44, 45). Polyvinyl chloride (PVC) wells 
of U-bottomed  microtiter plates (Dynatech, Inc., Alexandria, VA, catalog #01- 
010-2401) were coated with 100/~1 ofa 5 ug/ml solution of protein 4.1  in PBS 
or an unrelated control antigen such as BSA. After 2-4 h at room temperature 
in a humidified atmosphere,  the wells were emptied, were washed six to eight 
times with PBS, and were incubated  for 1 h at room temperature  with PBS 
made  10 mg/ml in BSA to block the remaining  nonspecific protein-binding 
sites on the plastic. The wells were again emptied  and washed as before, and 
incubated  for 2-4 h at room temperature  with various dilutions of anti-4.1 in 
PBS containing  10 mg/ml BSA. After emptying and further washing, 50,000 
cpm (5 ng) of ~2SI-labeled, affinity-purified, goat anti-rabbit  IgG in PBS made 
10 mg/ml in BSA were added and the plates were incubated  another 2-4 h at 
room temperature. After emptying and washing as before, the polyvinyl chloride 
wells were cut apart and each well was counted  in a Tracor. Analytic gamma 
counter (Tracor Analytic, Inc., Elk Grove Village, IL). 
For affinity chromatography,  protein 4.1 was covalently attached to Sepha- 
rose 4B (Pharmacia,  Inc., Piscataway, N J), activated with cyanogen bromide, 
by the method of March et al. (46) except that conjugation  was done in 0.2 M 
Na bicarbonate  at pH 8.4 rather than pH 9.5. Concentrations  of 0.4-1  mg of 
protein per ml of packed beads were routinely achieved. Affinity columns were 
prewashed successively with  10 vol of 0.1  M NaHCO3, 0.4 M NaCl, pH 8; 0.1 
M Na acetate, 0.4 M NaCI, pH 4; 0.1  M Na borate, 0.4 M NaCI, pH 8; and 
0.1  M NaHCO3, 0,2 M NaCI, pH 8. These washes were followed by 1% Triton 
X-100 in PBS; by 3 M urea, 10 mM Tris, pH 8; by 3 M potassium thiocyanate 
and then  by PBS. Ammonium sulfate-fractionated  or ion  exchange-purified 
antibodies were passed through the column, which was washed with 10-20 vol 
of PBS; several column volumes of 1% Triton X-100 in PBS; and 3 M urea, 
10 mM Tris, pH 8. Antibodies were then eluted with 3 M potassium thiocyanate 
and immediately dialyzed against several liters of PBS. Protein concentrations 
were determined  by measuring the optical density at 280 nm, using"  Eo.j~  ¢,n =  1.4 
(43). Goat anti-rabbit  IgG serum was purchased from Serasource, Inc. (Berlin, 
MA), and was affinity-purified as described above on a column of rabbit IgG. 
To prepare  an appropriate  control  antibody,  ammonium sulfate-fractionated 
anti-4.1 (78 #g) was passed through a column of 4. l-Sepharose containing  45 
ug of protein 4.1. A small portion  of the nonadherent  effluent was saved, and 
the remainder  was passed over a fresh column.  This was repeated three more 
times. The volumes of the saved fractions were normalized  to produce  equal 
antibody  concentrations  (assuming  no antibody  loss upon adsorption).  The 
fractions were then diluted  1:10 and used in a solid-phase RIA on 4.l-coated 
polyvinyl chloride wells to monitor removal of anti-4. I activity by the column. 
Antidinitrophenyl  (anti-DNP) and DNP coupled to BSA (DNP-BSA) were the 
gift of Dr. L. J. Wysocki (Massachusetts Institute  of Technology, Cambridge, 
MA). Antitropomyosin  binding protein  (anti-TMBP) was the gift of Dr. S. E. 
Hitchcock-deGregori (Carnegie-Mellon University, Pittsburgh, PA). 
Iodinations:  Antibodies were iodinated  by the chloramine-T  method 
as described by Hunter and Greenwood (47). Spectrin, filamin, and protein 4.1 
were iodinated  with Bolton-Hunter  reagent (New  England  Nuclear,  Boston, 
MA) by the method of Bolton and Hunter (48). 
Adsorption Assays:  Human erythrocyte ghosts, spectrin-depleted in- 
side-out vesicles, PMNs,  lymphocytes, or platelets were made  1 mM in  DFP 
and I ug/ml each in soybean trypsin inhibitor (Sigma Chemical Co.), pepstatin, 
chymostatin, antipain,  and leupeptin, and were homogenized on ice for 5 rain 
in a Teflon-pestled, Potter-Elvehjem type homogenizer attached to a 3/8-inch 
drill spun at 1,200 rpm. Increasing quantities (0-200 ug) of  total cellular protein 
were incubated in 5 mM EDTA, 0.1% Triton  X-100, 1% BSA, and 7.5 mg/ml 
nonimmune rabbit  lgG  in  PBS  in  the  presence  of 78  ug/ml ammonium 
sulfate-fractionated anti-4.1 or 0.4 ug/ml anti-DNP.  After shaking overnight at 
4"C, each sample was pelleted at 12,800 g for 15 rain and the supernatants were 
tested  for  remaining  antibody  activity.  They  were applied  to  the  wells of 
polyvinyl chloride  microtiter  plates that  had  previously been incubated  with 
0.5 ug of protein 4.1  or DNP-BSA and blocked with PBS made  10 mg/ml in 
BSA. After 4 h at room temperature,  the wells were emptied  and washed with 
PBS and 100 ~l of ~251-goat anti-rabbit  IgG (5 ng of antibody, 50,000 cpm) was 
added to each well After 4 h more, the wells were emptied, washed again, and 
bound radioactivity was measured. 
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by the method of Pryzwansky  et al. (49). Human venous  blood was cytocentri- 
fuged onto 12-mm-round  coverslips  (Carolina  Biological  Supply  Co., Burling- 
ton, NC) that had been prewashed with acetone and ethanol. The cells were 
fixed and permeabilized  in a buffered formalin-acetone  solution (49). Rabbit 
antibodies  were used at 5-50 #g/ml in PBS, and were followed  by a fluorescein 
isothiocyanate-labeled  goat anti-rabbit  IgG (Miles  Laboratories,  Inc.),  used at a 
dilution of 1:40 to 1:500. Coverslips  were mounted in 90% glycerol/10%  PBS 
and sealed with nailpolish.  The slides  were examined  with a Zeiss Universal 
microscope  (Carl Zeiss,  Inc., New York) equipped for epifluorescence,  using  a 
#487710 fiuorescein  isothioeyanate  filter set. 
Electrophoretic  Transfer Assays:  Electrophoretic transfer assays 
and spectrin  binding  assays  were performed  as previously  described  (36). 
Immunopeptide Maps:  Whole  PMNs (pretreated  with 1 mM DFP) 
and erythrocyte  ghosts were boiled for 2 rain in 0.125 M Tris-HC1, pH 6.8, 
0.5% SDS, 10% glycerol,  and 0.0001% bromphenol  blue. Digestion  was then 
carried  out as described  by Cleveland  et al. (50)  with Staphylococcus  aureus  V8 
protease (Miles  Laboratories,  Inc.), using an enzyme to protein mass ratio of 
1:500. The proteolytically  digested  cell proteins  were electrophoresed  on adja- 
cent lanes of a 10% SDS polyacrylamide  gel, transferred  to nitrocellulose,  and 
stained  with anti-4.1 as described  previously.  Although  peptides  were generated 
from all the cellular  proteins,  only those that were derived  from protein 4.1 or 
from a 4. l-like protein and that retained their immunogenicity  were resolved 
on the resulting  autoradiogram. 
RESULTS 
Antibody Activity and Specificity 
Immune anti-4.1 was a nonprecipitating antibody. No pre- 
cipitin lines were observed in double immunodiffusion tests 
(data not shown); therefore, anti-4.1 was tested for activity in 
solid-phase RIAs.  Ammonium  sulfate-fractionated anti-4.1 
antibody could be detected at a concentration of <0.5 #g/ml, 
and binding of anti-4.1 to 4.1-coated wells reached a plateau, 
demonstrating that the binding to protein 4.1  was saturable 
(Fig. 1). 
To  demonstrate  the  specificity of the  anti-4.1  antibody, 
fresh erythrocyte ghosts and purified protein 4.1 were electro- 
phoresed in adjacent wells of a  10%  SDS polyacrylamide gel, 
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DILUTION  OF  ANTIBODY 
Solid-phase RIA showing that the binding of anti-4.1 to 
4.1 -coated polyvinyl chloride wells is saturable. Ammonium-sulfate 
fractionated anti-4.1  (8  mg/ml)  was  diluted  as  shown.  Specific 
radioactivity bound  (percent)  was  calculated by  subtracting  the 
binding of preimmune serum from the binding of immune serum. 
Percent of specific activity bound represents the maximum number 
of counts bound. 
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transferred to nitrocellulose paper, and stained with Amido 
Black  or  with  unlabeled,  ion-exchange  or  affinity-purified 
anti-4.1,  followed  by  '2~I-labeled goat  anti-rabbit  IgG.  As 
shown in Fig. 2B, only protein 4.1 (78,000 Mr) was visualized 
by the  antibody when  erythrocyte ghosts were  stained.  No 
protein bands were seen with the adsorbed anti-4.1 antibody 
or with t25I-labeled goat anti-rabbit IgG alone (Fig. 2 C). Thus, 
the labeling of protein 4.1  was not due to nonspecific adher- 
ence of antibodies to the protein. Because the anti-4.1  anti- 
body  was  highly  specific  for  its  respective antigen,  it  was 
generally purified only by ion-exchange chromatography. 
Identification of a Protein 4.1 Analogue in 
Nonerythroid Cells 
To search for protein 4. I or a 4. I analogue in nonerythroid 
cells, erythrocyte ghosts, total cellular protein from  human 
PMNs, platelets, and a  lymphocyte-monocyte fraction were 
electrophoresed on  a  10%  SDS-polyacrylamide gel,  trans- 
ferred to  nitrocellulose, and  stained with  anti-4.1  antibody. 
The results are shown in Fig. 3.  Autoradiography showed a 
single protein band in all of the cells (Fig. 3 B). However, in 
the nonerythroid cells, the visualized band had a  lower mo- 
lecular  weight  (~68,000  Mr)  than  erythrocyte  protein  4.1 
(78,000-80,000  Mr).  Staining  with  anti-4.1  previously ad- 
sorbed against protein 4.1 did not visualize any protein bands 
(Fig. 3 C). 
To  test  the  possibility that  this  lower  molecular weight 
protein could result from the cleavage of a  78,000  Mr non- 
erythroid 4. l-like protein during cell solubilization, we added 
an array of protease inhibitors:  10 mM N-ethylmaleimide; 1 
mM DFP; 50/~M Ep-475 (a sulfhydryl protease inhibitor); 1 
~g/ml each of leupeptin, antipain, chymostatin, and pepsta- 
tin;  and  a  mixture  containing all of these inhibitors.  Even 
when  all were  present before and during solubilization, we 
were unable to detect a  nonerythroid protein of 78,000  M,. 
FIGURE 2  Specificity  of anti-4.1.  Erythrocyte  ghosts and  protein 
4.1 were electrophoresed on a 10% SDS polyacrylamide  gel, trans- 
ferred  to  nitrocellulose, and  stained  with  ion-exchange purified 
anti-4.1  or with a 4.1-adsorbed anti-4.1  antibody. (A) Coomassie 
Blue-stained  gel of 30/~g of ghosts (G) and  10/~g of protein 4.1 
(4.1). (B) An autoradiogram of the electrophoretically-transferred 
proteins from an identical gel, stained with anti-4.1. (C) An autora- 
diogram of similarly transferred  proteins of a  ghost  preparation 
stained  with  the  4.1-adsorbed  anti-4.1  antibody.  No  binding  is 
visible. A similar blank pattern was observed when PBS was substi- 
tuted for the first antibody, precluding the possibility of nonspecific 
binding of '2Sl-goat  anti-rabbit IgG to the transferred  proteins. FIGURE 3  Detection of a  4.l-like  protein  in  nonerythroid cells. 
Total cellular protein (100 pg) from polymorphonuclear  leukocytes 
(PMN), platelets  (PI), and a lymphocyte-monocyte fraction (L) was 
electrophoresed on an SDS polyacrylamide gel, along with 30 pg 
of erythrocyte ghosts (G). After transfer,  the nitrocellulose sheets 
were stained with anti-4.1  or a 4.1-adsorbed anti-4.1 antibody. (A) 
Coomassie  Blue-stained  gel.  (B) An autoradiogram of transferred 
proteins from a duplicate gel stained with anti-4.1.  (C) An autora- 
diogram of transferred  ghosts and whole PMNs stained with a 4.1- 
adsorbed anti-4.1 antibody. 
FIGURE 4  Immunopeptide  maps. Erythrocyte  ghosts  (G)  and 
polymorphonuclear leukocytes (PMN) were digested with Staphy- 
lococcus aureus V8 protease, run on SDS gels, transferred  to nitro- 
cellulose paper,  and stained  with anti-4.1.  On the left are  undi- 
gested and digested  erythrocyte ghosts. On the right,  PMNs and 
digested PMNs. Both digested preparations, when stained with anti- 
4.1,  show an  immunologically reactive doublet on the autoradi- 
ogram (arrow). 
In addition, nonerythroid cells were tested for their ability to 
digest erythroid protein 4.1 to a 68,000 Mr protein. ]2~I-labeled 
protein 4.1  was  added to  50  #g  of platelet  protein  in  the 
absence of protease inhibitors, solubilized, incubated for pe- 
riods up to  1 h at 25"C, and analyzed by gel electrophoresis 
and autoradiography. Even under these provocative condi- 
tions no degradation of protein 4.1 was observed. 
To demonstrate a structural relationship between 4.1  and 
the 4.l-like protein, immunopeptide maps were performed 
(Fig. 4). Erythrocyte ghosts and PMNs digested with Staphy- 
lococcus aureus  V8  protease showed homology between the 
erythroid and  the  nonerythroid protein in  the  form of an 
immunoreactive doublet visualized at the bottom of the gel. 
Adsorption Studies 
To  further  assess  the  degree  of homology between  the 
erythroid and the nonerythroid proteins, an adsorption study 
was performed to determine what percentage of  the antibodies 
that react with erythroid protein 4.1  also react with the 4. l- 
analogue(s) in other cell types. Various whole cell homoge- 
nates were assayed for the ability to adsorb anti-4.1 antibodies 
(Fig.  5). Erythrocyte ghosts removed ~75%  of the antibody 
activity,  whereas  spectrin-depleted  membrane  vesicles  re- 
moved ~90% of the antibody activity (presumably removing 
spectrin from the  membrane rendered additional antibody 
binding sites more accessible).  PMNs and platelets removed 
60-70% and 20-35% of the anti-4.1 activity, respectively. It 
is  probable that  removal of antibody activity plateaued at 
these lower values for two reasons: (a) that not all the sites to 
which anti-4.1  antibodies bound on the purified'protein were 
accessible  in the homogenized cell preparations (and differ- 
ences in  antigen  accessibility between platelets and  PMNs 
may explain the different values each attained); and (b) the 
nonerythroid protein is certainly not identical to the eryth- 
rocyte protein (and may differ between PMNs and platelets), 
and  probably does not contain  some domains to  which  a 
subpopulation of the antibodies are directed. 
To control for specificity of antibody adsorption, an affin- 
i00~ .................................................  ANTI-DNP 
PLATELETS 
/i  ~  "~-.  •PMNs 
|i  f"  ~  RBC GHOSTS 
,o[  i.... ....  . 
In["  ""  "  .......  ,~  .......  SPECTRIN" 
'v/  "= .................. I  DEPLETED 
'"=  lOVs 
25 50  I00  1,50 200  250  300~:)0 
MICROGRAMS  OF PROTEIN  ADDED 
FIGURE 5  Adsorption of antibody  activity by cell lysates. Cells were 
treated as described in  the text and  incubated with  antidinitro- 
phenyl (ANT/-DNP) or anti-4.1.  In all cell types amd at all levels of 
cellular protein tested, anti-DNP activity remained at 100%. Shown 
are  polymorphonuclear leukocytes  (PMNs), platelets,  erythrocyte 
ghosts (RBC), and spectrin-depleted erythrocyte membranes (lOVs). 
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the above proteins. Because erythrocytes, PMNs, and platelets 
do not contain DNP,  anti-DNP activity should not be re- 
moved by the cell homogenates unless (a) endogenous pro- 
teases  are destroying the antibody,  yielding falsely  positive 
results; (b) antibodies are binding nonspecifically, and/or via 
Fc receptors; or (c) antibodies are "trapped" in  membrane 
vesicles.  As  shown  in  Fig.  5,  however,  anti-DNP  activity 
remained constant (i.e., no anti-DNP activity was removed at 
all levels of cellular protein tested), indicating that PMNs and 
platelets did indeed specifically bind anti-4.1  antibodies. 
When antibody removal was  corrected for differences in 
cell mass,  PMNs and platelets were found to be 50 and  10 
times more effective per cell, respectively, at removing anti- 
4.1 activity than were erythrocytes. 
Location of the 4. l-like Protein  in 
Nonerythroid Cells 
lmmunofluorescent staining of peripheral blood was  not 
routinely performed, due to the high numbers of autofluores- 
cent cells present in the preparations after the fixation step. 
Difficulties were also encountered with fixatives used to retain 
cell morphology which increased nonspecific fluorescence. To 
optimize morphologic integrity and to minimize nonspecific 
adherence  of antibodies,  we  used  the  buffered  formalin- 
acetone  preparation  developed  by  Pryzwansky  et  al.  (49) 
rather  than  the  traditional  acetone  permeabilization  and 
formaldehyde fixation. Even then, however, only a portion of 
the preparations had low background fluorescence. The rea- 
son for this variability was not determined. 
In  good preparations,  staining  of PMNs and  monocytes 
(Fig. 6) or lymphocytes (data not shown) with anti-4.1  yielded 
a diffuse, cytoplasmic fluorescence that excluded the nucleus. 
Staining of platelets was primarily membrane-associated (Fig. 
6).  Treatment with  similar  concentrations of 4.l-adsorbed 
anti-4.1  (data not shown) or anti-DNP resulted in either faint 
or nonexistent background staining. 
Because  protein  4.1  is  an  important  constituent  of the 
erythrocyte skeleton, we searched for the 4.l-like protein in 
the cytoskeletons of platelets.  As shown in Fig. 7, the 4. l-like 
protein was associated with the Triton X-100-insoluble cyto- 
skeletal fraction of platelets and did not appear in either of 
the Triton X-100-soluble fractions. In a  similar experiment 
(Fig.  7),  the cross-reactive protein was also detected in the 
cytoskeleton of P815 cells (a murine cell line with lymphoid 
characteristics [51 ]). 
Reactivity of Cell Homogenates with  1251-Spectrin 
or 1251-Filamin 
Protein 4.1 has been identified as a spectrin-binding protein. 
We therefore assayed the ability of protein 4.1  and the 4. l- 
like protein(s) to bind to ~25I-spectrin  or ~25I-filamin  (an actin- 
binding protein) when they were immobilized on nitrocellu- 
lose  paper.  Treatment of the transferred proteins with  ~25I- 
spectrin dimer  resulted in  the  staining  of protein 4.1  and 
ankyrin in the erythrocyte ghosts,  both previously identified 
FIGURE  6  Immunofluorescence photomicrographs. Peripheral blood cells were fixed and stained with affinity-purified anti-4.1. 
Antidinitrophenyl  (ANTJ-DNP)  or  4.1-adsorbed  anti-4.1  (ANTI-4.1)  were  used  as  control  antibodies.  Neither  control  antibody 
yielded any specific staining. Final concentrations of antibodies were 25-50/~g/ml.  Fluorescein isothiocyanate labeled goat anti- 
rabbit  IgG  was  used  at a  dilution of  1:40 to  1:500.  Exposures of fluorescence  pictures  were  1-2  min.  I,  an  erythrocyte; 2,  a 
polymorphonuclear leukocyte; 3, a platelet; and 4, a monocyte. Bar,  7 #m. 
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was observed in the lanes containing the nonerythroid cells 
when either 125I-spectdn (Fig.  8B) or  125I-filamin (Fig.  8(7) 
was  used,  indicating  that  the  cross-reactive,  nonerythroid 
proteins detected by anti-4.1  did not bind either spectrin or 
filamin under these conditions. 
Reactivity with Previously Identified Actin- 
associated Proteins 
Finally, we  attempted  to  determine whether any of the 
previously identified and  isolated  actin-associated proteins 
FIGURE  7  Localization of the 4.l-like protein in the cytoskeletons 
of platelets and P815 cells. Approximately 150/~g of platelet protein 
obtained at different stages of the extraction procedure, and  106 
cell equivalents of P815 cells and P815 cytoskeletons were run on 
an  SDS gel,  transferred  to  nitrocellulose paper,  and stained  with 
anti-4.1.  Shown  is an  autoradiogram  of a transfer  of erythrocyte 
ghosts (G), Triton X-100-soluble platelet proteins (PS), Triton X-100- 
insoluble platelet proteins (PP), whole P815 cells  (815), and  P815 
cytoskeletons (815P).  The 4.l-like protein appears in the cytoskel- 
etal fraction of both cell types,  and, in this preparation of platelet 
cytoskeletons, shows some proteolytic degradation. 
FIGURE 8  Reactivity of electrophoretically transferred  cell homog- 
enates  with  ~Sl-spectrin  or  ~ZSl-filamin. Transferred  proteins  of 
erythrocytes ghosts  (G), polymorphonuclear leukocytes (PMN), a 
lymphocyte-monocyte fraction (L), and platelets (PI)  were incubated 
with x251-spectrin  or a2sl-filamin as described in the text. (A) Coo- 
massie Blue-stained  gel. (B) Autoradiogram of transferred  proteins 
from  a duplicate gel stained  with 1251-spectrin. (C) Autoradiogram 
of similarly transferred  proteins stained with 1251-filamin.  Notice that 
~Z5l-spectrin (B) stains both protein 4.1  and ankyrin. ~251-filamin  (C) 
stains only unidentified lower molecular weight proteins. 
from leukocytes or  platelets was  the  4.l-like  nonerythroid 
analogue. The most likely candidate was acumentin, a protein 
of ~65,000  Mr  that  caps actin  filaments (37).  Preliminary 
studies (52) showed weak cross-reactivity between rabbit 4.1 
and rabbit acumentin. To determine if this observation was 
valid with human proteins, we used purified human acumen- 
tin in a solid-phase RIA, and assessed its ability to bind our 
anti-4.1  antiserum. Essentially no binding was observed, in- 
dicating that acumentin was not the nonerythroid analogue 
(data not shown). We then focused our attention on a 66,000 
Mr TMBP isolated from human platelets (53, 54) that inhibits 
actin polymerization. When anti-TMBP was used in a solid- 
phase RIA, it did not bind to protein 4.1  (data not shown), 
and therefore is not the nonerythroid analogue of protein 4. I. 
DISCUSSION 
Protein 4.1  is  an important component of the erythrocyte 
membrane  skeleton.  In  vitro  it  functions  to  enhance  the 
spectrin-actin binding interaction (3,  17-19).  In  vivo it  is 
required for the maintenance of skeletal integrity: individuals 
homozygous for a rare form of hereditary elliptocytosis lack 
all  protein 4.1  and  display marked red cell  fragmentation, 
poikilocytosis, osmotic fragility, and hemolysis (55, 56). 
To facilitate the study of  this protein, we raised an antibody 
to purified protein 4.1  and demonstrated its specificity.  Al- 
though protein 4.1 was previously thought to be an exclusively 
erythroid protein, we have used our antibody to show the 
existence of a  protein 4.1  analogue in leukocytes, lymphoid 
cells, and platelets.  This cross-reactive  protein has an apparent 
molecular weight of ~68,000. We cannot absolutely exclude 
the possibility, however, that a nonerythroid protein of 78,000 
Mr actually exists,  but is not protected by treatment with a 
wide battery of protease inhibitors. 
Nonerythroid protein 4.1  is associated with the cytoskele- 
tons  of platelets and  of P815  cells,  and  it  is  found in  the 
cytoplasm of leukocytes. We did not attempt to determine 
whether it is also associated with the cytoskeleton of the latter 
cells,  although  this  seems a  reasonable possibility.  In  vitro 
binding assays using the technique of electrophoretic transfer 
to nitrocellulose paper of proteins separated on SDS polyac- 
rylamide gels, failed to detect binding of spectrin or filamin 
to the 4. l-like protein. In addition, solid-phase RIAs demon- 
strated no detectable cross-reactivity  between human acumen- 
tin or human TMBP and protein 4.1. 
If there are two forms of protein 4.1, what is their signifi- 
cance? Actin, also a structural protein, is encoded by a mul- 
tigene family (57). As many as 17 genes for actin are present 
in a single organism (e.g., Dictyostelium)  (58), but the multiple 
actin genes and proteins are expressed at different times and 
in different tissues.  Investigators have suggested that perhaps 
an ancestral actin gene has duplicated and diverged. It could 
be advantageous to be able to activate an actin gene selectively 
for a specific tissue rather than to modulate one actin gene 
differentially in different tissues.  In the case of protein 4. l, 
gene duplication at the level of a pluripotent, ancestral stem 
cell could explain the existence of both erythroid and non- 
erythroid forms of the protein. 
Conversely, it is conceivable that there may be only one 
gene  for protein  4.1,  containing  multiple  exons  encoding 
several  domains.  Different 4.1-related proteins might  then 
express different but overlapping domains. Different messen- 
ger RNA splicing  mechanisms may exist in  leukocytes and 
SPIEGEL  ET  AL.  Nonerythroid  Protein 4.1  891 erythrocytes, allowing a 68,000 Mr protein to be translated in 
one cell type and a 78,000 Mr protein in the other. 
After our initial  report of the existence  of protein 4.1  in 
nonerythroid cells (59), Cohen et al.  (60, 61) discovered two 
4.1  analogues in  fibroblasts  of apparent  molecular weights 
78,000  and 90,000.  The discrepancy in the sizes of the 4.1 
analogues detected in our work and in that of Cohen and his 
co-workers may be due to the different antibodies used (which 
may detect different proteins), to the way that we prepared 
the cells, or to the fact that we examined different cells. The 
possibility that we are detecting a proteolytic fragment of the 
proteins they saw must also be considered. In their hands, our 
antibody detects proteins of both  molecular weights 78,000 
and  68,000  (62),  suggesting  (a)  that  our antisera recognize 
different parts of the 4.1  molecule, and (b) that differences in 
cell preparation contribute to the presence of different molec- 
ular weight proteins.  Although we went to great lengths to 
prevent proteolysis and to detect 4.1-proteolytic activity, we 
will  not be  able  to  absolutely  exclude  proteolysis until  the 
synthesis of the 4. l-like protein(s) has been studied in a cell- 
free system or its gene(s) has been isolated and characterized. 
It  is  interesting  that  adsorption  studies  showed  a  large 
amount of apparent homology between erythrocyte 4.1  and 
the  4.l-like  protein.  Human  platelets  and  PMNs  adsorbed 
30-60%  of anti-human  erythrocyte  4.1  activity.  This  may 
indicate extensive homology between the erythroid and non- 
erythroid proteins or a limited spectrum of epitopes on eryth- 
rocyte 4.1  that are seen by the anti-4.1  antibody. 
If there is extensive structural homology between the two 
proteins, they may also exhibit functional homology. In the 
erythrocyte,  protein  4.1  is  crucial  for  the  maintenance  of 
skeletal integrity, and in vitro it is required for the amplifica- 
tion  of spectrin-actin  interactions.  The  4.l-like  protein  is 
found  associated  with  the  cytoskeletons of platelets,  P815, 
and possibly  other cells.  Other erythrocyte skeletal proteins 
have been  located in  nonerythroid cells:  both  spectrin and 
ankyrin have been found in brain and liver (21, 25), and brain 
spectrin retains the ability to bind to erythrocyte ankyrin (31). 
Recently,  brain  spectrin  has  also  been  shown  to  form  a 
complex with actin and erythrocyte protein 4.1  (63).  As in 
the erythrocyte, the interaction of brain spectrin with protein 
4.1  enhances its attachment to actin. We suspect the 4. I-like 
protein(s) also function to augment the interactions between 
spectrinlike proteins and actin in nonerythroid cells. Although 
we could not detect spectrin-binding to the nonerythroid 4.1, 
our studies were limited to nitrocellulose transfers. Purifica- 
tion of the 4. l-like protein, the study of its interactions with 
other skeletal proteins, and a  survey of its location in non- 
erythroid cells containing spectrin and ankyrin analogues are 
needed. 
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